-
公开(公告)号:EP1206447B1
公开(公告)日:2004-02-25
申请号:EP00969245.0
申请日:2000-08-23
申请人: Wilex AG
IPC分类号: C07C279/18 , A61K31/155
CPC分类号: C07D277/54 , A61K31/155 , A61K31/165 , A61K31/17 , A61K31/18 , A61K31/27 , A61K31/426 , A61K31/655 , C07C279/18 , C07C311/19
摘要: The present invention relates to novel selective inhibitors of the urokinase plasminogene activator (uPA, EC 3.4.21.31) of the aryl guanidine type.
-
公开(公告)号:EP1267854A2
公开(公告)日:2003-01-02
申请号:EP01938022.9
申请日:2001-03-15
发明人: MAGDOLEN, Viktor , SPERL, Stefan , STÜRZEBECHER, Jörg , WILHELM, Olaf , ARROYO-DEPRADA, Nuria , MORODER, Luis , HUBER, Robert , JACOB, Uwe , BODE, Wolfram
IPC分类号: A61K31/00
CPC分类号: C07C279/18 , A61K31/155 , C07C2603/74
摘要: The invention relates to novel selective inhibitors of the urokinase plasminogen activator (uPA, EC 3.4.21.31), of the arylguanidine type.
摘要翻译: 由包含氢键供体和受体基团的侧链取代的芳基 - 胍衍生物(I)是新的。 是由包含氢键供体和受体基团的侧链取代的式(I)的芳基胍衍生物及其盐,是新的。 [图] Ar:芳族或杂芳族环系; X1-CR3R4-C(= X2)-CR6R7R8,-NH-C(O)-CR6R7R8或-CR3R4-C(= X2)-NHR8; R 1 H或(全部任选取代的)烷基,烯基,炔基,芳基和/或杂芳基; (R3)3,-C(R3)2C(R3)3,-OC(R3)3或-OC(R3)2C(R3)3; R3H或卤素(特别是F); R4-R7H或(全部任选取代的)烷基,烯基或炔基,R4或R5任选地与R6或R7键合,条件是R4和R5中至少一个以及R6和R7中的至少一个含有氢键供体基团; R8H; 烷基,烯基,炔基,芳基和/或杂芳基(全部被取代); 或SO2R9; 烷基,烯基,炔基,芳基和/或杂芳基; X2氢键受体基团,特别是NH,NR10,O或S; R10烷基,烯基或炔基(全部任意取代); m:0-4。 - 活动:细胞抑制。 没有给出生物数据。 - 作用机制:尿激酶纤溶酶原激活物(uPA)抑制剂; 尿激酶(UK)抑制剂
-
公开(公告)号:EP1267854B1
公开(公告)日:2007-11-21
申请号:EP01938022.9
申请日:2001-03-15
发明人: MAGDOLEN, Viktor , SPERL, Stefan , STÜRZEBECHER, Jörg , WILHELM, Olaf , ARROYO-DEPRADA, Nuria , MORODER, Luis , HUBER, Robert , JACOB, Uwe , BODE, Wolfram
IPC分类号: A61K31/00
CPC分类号: C07C279/18 , A61K31/155 , C07C2603/74
摘要: The invention relates to novel selective inhibitors of the urokinase plasminogen activator (uPA, EC 3.4.21.31), of the arylguanidine type.
-
4.DIAGNOSTISCHER UND THERAPEUTISCHER EINSATZ VON ANTIKÖRPERN GEGEN DEN UROKINASE-REZEPTOR 有权
标题翻译: 抗该尿激酶受体诊断和治疗用途公开(公告)号:EP1173765A1
公开(公告)日:2002-01-23
申请号:EP00917083.8
申请日:2000-04-13
申请人: Wilex AG
发明人: SCHMITT, Manfred , NOACK, Frank , MAGDOLEN, Viktor , GRAEFF, Henner , LUTHER, Thomas,Institut für Pathologie , ALBRECHT, Sybille,Institut für Pathologie , MÜLLER, Martin,Institut für Pathologie , WILHELM, Olaf
IPC分类号: G01N33/574 , G01N33/577 , G01N33/68 , A61K39/395 , A61K47/48 , A61K51/10 , C12N15/13 , C07K16/28 , C07K19/00
CPC分类号: C07K16/28 , A61K47/6849 , A61K51/1027 , A61K2039/505 , C07K16/2896 , C07K2317/565 , C07K2317/622 , G01N33/574 , G01N33/57492 , G01N33/582
摘要: The invention relates to a method and to a reagent kit for detecting cells in a biological sample while using a double fluorescence technique, as well as to the diagnostic and therapeutic use of amino acid sequence-specific antibodies against the urokinase receptor exhibiting a high affinity to tumor cell-expressed receptors.
-
5.HERSTELLUNG POLYKLONALER, MONOSPEZIFISCHER ANTIKÖRPER GEGEN DIE UPAR-VARIANTEN DEL4, DEL5 UND DEL4+5 SOWIE DEREN VERWENDUNG FÜR DIAGNOSTISCHE UND THERAPEUTISCHE ZWECKE 有权
标题翻译: 多克隆的生产,MONO特异性抗体反对UPAR VARIANTS DEL4,DEL5和DEL4 + 5和它们用于治疗目的和诊断公开(公告)号:EP1386152B1
公开(公告)日:2011-12-21
申请号:EP02732565.3
申请日:2002-04-05
申请人: Wilex AG
IPC分类号: G01N33/48
CPC分类号: C07K14/705 , A61K2039/505 , C07K16/30 , C07K16/3015 , C07K16/3069 , C07K2317/34
摘要: The invention relates to the production of specific antibodies to detect human tumour-associated urokinase-type plasminogene activator receptor (uPAR) deletion variants in biological samples and the diagnostic and therapeutic use thereof.
-
6.DIAGNOSTISCHER UND THERAPEUTISCHER EINSATZ VON ANTIKÖRPERN GEGEN DEN UROKINASE-REZEPTOR 有权
标题翻译: 抗该尿激酶受体诊断和治疗用途公开(公告)号:EP1173765B1
公开(公告)日:2007-01-03
申请号:EP00917083.8
申请日:2000-04-13
申请人: Wilex AG
发明人: SCHMITT, Manfred , NOACK, Frank , MAGDOLEN, Viktor , GRAEFF, Henner , LUTHER, Thomas, Institut für Pathologie , ALBRECHT, Sybille, Institut für Pathologie , MÜLLER, Martin, Institut für Pathologie , WILHELM, Olaf
IPC分类号: G01N33/574 , G01N33/577 , G01N33/68 , A61K39/395 , A61K47/48 , A61K51/10 , C12N15/13 , C07K16/28 , C07K19/00
CPC分类号: C07K16/28 , A61K47/6849 , A61K51/1027 , A61K2039/505 , C07K16/2896 , C07K2317/565 , C07K2317/622 , G01N33/574 , G01N33/57492 , G01N33/582
摘要: The invention relates to a method and to a reagent kit for detecting cells in a biological sample while using a double fluorescence technique, as well as to the diagnostic and therapeutic use of amino acid sequence-specific antibodies against the urokinase receptor exhibiting a high affinity to tumor cell-expressed receptors.
-
7.HERSTELLUNG POLYKLONALER, MONOSPEZIFISCHER ANTIKÖRPER GEGEN DIE UPAR-VARIANTEN DEL4, DEL5 UND DEL4+5 SOWIE DEREN VERWENDUNG FÜR DIAGNOSTISCHE UND THERAPEUTISCHE ZWECKE 有权
标题翻译: 多克隆的生产,MONO特异性抗体反对UPAR VARIANTS DEL4,DEL5和DEL4 + 5和它们用于治疗目的和诊断公开(公告)号:EP1386152A2
公开(公告)日:2004-02-04
申请号:EP02732565.3
申请日:2002-04-05
申请人: Wilex AG
IPC分类号: G01N33/48
CPC分类号: C07K14/705 , A61K2039/505 , C07K16/30 , C07K16/3015 , C07K16/3069 , C07K2317/34
摘要: The invention relates to the production of specific antibodies to detect human tumour-associated urokinase-type plasminogene activator receptor (uPAR) deletion variants in biological samples and the diagnostic and therapeutic use thereof.
-
公开(公告)号:EP0971948B1
公开(公告)日:2003-08-13
申请号:EP98919267.9
申请日:1998-04-14
申请人: Wilex AG
发明人: KESSLER, Horst , GRAEFF, Heinrich , SCHMITT, Manfred , MAGDOLEN, Viktor , WILHELM, Olaf, G. , RIEMER, Christoph , BÜRGLE, Markus
IPC分类号: C07K7/00
CPC分类号: C12N9/6462 , C12Y304/21073
-
公开(公告)号:EP1098651B1
公开(公告)日:2003-01-08
申请号:EP99936570.3
申请日:1999-07-20
申请人: Wilex AG
IPC分类号: A61K31/495 , A61P35/00
CPC分类号: A61K31/495 , A61K51/0406 , A61K51/0455 , A61K51/0459 , C07D295/205
摘要: The invention relates to the use of derivatives of 3-amidino-phenyl-alanine as urokinase inhibitors for treating malignant tumors and the formation of metastases thereof.
-
-
-
-
-
-
-
-